What is KMTS's EBITDA?

KMTS (KMTS) reported EBITDA of -$32.78M in Q4 2025.

How has KMTS's EBITDA changed year-over-year?

KMTS's EBITDA decreased by 75.2% year-over-year, from -$18.71M to -$32.78M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

KMTS KMTS EBITDA

EBITDA at other companies

iRhythm Holdings, Inc. IRTC

-$11.14M+59.3%

Merit Medical SystemsMMSI

$74.65M+6.2%

HaemoneticsHAE

$94.78M+7.6%

AbbottABT

——

Boston ScientificBSX

——

MedtronicMDT

——

Other financials

Income statement

See full

Revenue$24.6M+62.7%

Gross profit$12.9M+97.1%

Operating income-$34.8M-68.8%

Net income-$34.2M-58.8%

EPS (diluted)-$0.61+51.2%

Balance sheet

See full

Cash & equivalents$291.3M+436%

Total debt$43.8M—

Total assets$379.3M—

Cash flow

See full

Operating cash flow-$18.4M-2.1%

CapEx$9.8M+141%

Free cash flow-$28.2M-27.7%

Valuation

See full

Market cap$1.29B+70.8%

Enterprise value$1.04B—

P/S15.4×—

Profitability

See full

Gross margin48.8%+15.1pp

Operating margin-171.5%+12.9pp

Net margin-173%+0.8pp

FCF margin-142.9%-25.3pp

Returns & leverage

See full

Current ratio7.3×—

Where this comes from

Calculated from KMTS’s reported figures.

−$34.8Mebit+

$2.0MDepreciation Depletion & Amortization

=-$32.78M

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is KMTS's EBITDA?: KMTS (KMTS) reported EBITDA of -$32.78M in Q4 2025.
How has KMTS's EBITDA changed year-over-year?: KMTS's EBITDA decreased by 75.2% year-over-year, from -$18.71M to -$32.78M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.